Search
Search
Joseph J. Allen, OD, FAAO, Dipl ABO
Show Description +
Joseph J. Allen, OD, FAAO, Dipl ABO, goes over what you need to know about the recently FDA-approved, nonpreserved cyclosporine ophthalmic solution 0.1% (Vevye, Novaliq) for treating the signs and symptoms of dry eye disease. He discusses what makes the drop unique compared with other cyclosporine products, its mechanism of action and dosing information, what the data have shown about its effectiveness, and lingering questions he still has about the semiflurinated alkane drop.
Posted: 3/26/2024
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO, goes over what you need to know about the recently FDA-approved, nonpreserved cyclosporine ophthalmic solution 0.1% (Vevye, Novaliq) for treating the signs and symptoms of dry eye disease. He discusses what makes the drop unique compared with other cyclosporine products, its mechanism of action and dosing information, what the data have shown about its effectiveness, and lingering questions he still has about the semiflurinated alkane drop.
Posted: 3/26/2024
_1701789080.png?auto=compress,format&w=180)
.mp4.00_05_41_04.Still001_1680887186.jpg?auto=compress,format&w=180)
.00_13_09_19.Still001_1676069079.jpg?auto=compress,format&w=180)
Please log in to leave a comment.